Novartis Fends Off US Fingolimod Competition – For Now
No Gilenya Generics Expected ‘For At Least The Next Two Years’ In US, Originator Says
• By David Wallace
Novartis expects US protection for Gilenya to stretch years into the future • Source: Oakozhan / Alamy Stock Photo 
